RepliCel Life Sciences Inc (OTCQB:REPCF)

0.277
Delayed Data
As of 3:05pm ET
 -0.01 / -3.48%
Today’s Change
0.26
Today|||52-Week Range
0.77
-10.65%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization1.1K784.31772.71828.16
 
 
 
 
 
 
Operating ExpensesGross Income-1.1K-784.31-772.71-828.16
 
 
 
 
 
General Expenses1.3M1.3M1.9M968.2K
 
 
 
 
 
Research And Development311.1K245.3K996.8K635.8K
 
 
 
 
 
Total Operating Expenses1.3M1.3M1.9M969.0K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.3M-1.3M-1.9M-969.0K
 
 
 
 
 
Other Expenses-3.0K-9.8K-4.4K19.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.3M-1.3M-1.9M-948.6K
 
 
 
 
 
Net Income-1.3M-1.3M-1.9M-948.6K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.1M16.7M18.6M18.6M
 
 
 
 
 
Shares To Calculate EPS Diluted11.1M16.7M18.6M18.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.08-$0.08-$0.10-$0.05
 
 
 
 
 
EPS Diluted-$0.12-$0.08-$0.10-$0.05